Synokem Pharmaceuticals
Synokem Pharmaceuticals is an Indian CDMO and pharma manufacturer founded in 1983, operating three WHO-GMP-certified facilities that produce tablets, capsules, injectables, and hormonal products across 400+ formulations, serving pharmaceutical companies, government healthcare institutions, and export markets across 35+ countries.
- Company typePrivate
- Founded1983
- HeadquartersDelhi, India
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Synokem Pharmaceuticals does
Synokem Pharmaceuticals Ltd. is an Indian pharmaceutical company founded in 1983 and headquartered in Delhi, operating an integrated CDMO-plus-product platform across four verticals: contract manufacturing/CDMO services for pharma and biotech customers; a Branded Rx/Ethical Division for prescription medicines in India; an Institutional Business supplying government departments, public sector hospitals, state procurement corporations, Indian Railways, and the Jan Aushadhi program; and an International Business exporting WHO-GMP-certified formulations to more than 30-35 countries across Africa, LATAM, the Middle East, CIS, SAARC, and Southeast Asia.
Its core manufacturing is delivered through three wholly-owned subsidiaries with WHO-GMP and cGMP certification: Synokem Lifesciences (Plant 3, incorporated 2022; tablets, capsules, liquids and home of the DSIR-certified R&D center including the F&D team and Analytical Development Laboratory), Nitin Lifesciences (acquired 2023; CDMO focused on Small Volume Parenteral products — glass vials, dry powder injections, glass ampoules, lyophilized injections, eye/ear drops — with 30+ years of aseptic expertise and three facilities in Karnal and Paonta Sahib), and Kemsyn Lifesciences (branded generics, 300+ SKUs). Aggregate annual capacity exceeds 1 billion general tablets, 200 million capsules, 207 million glass vials, 420 million ampoules, and substantial lyophilized and cephalosporin output; product breadth covers 400+ formulations across acute, chronic, hormonal, and sterile therapeutic segments.
The business model combines three distinct go-to-market motions: enterprise field sales for CDMO contracts under Product-to-Product (P2P) and Loan License multi-year arrangements priced on a quote basis; sales-led institutional tender participation and distributor relationships for the Branded Rx Division; and export-led international distribution supported by 30+ country regulatory approvals. Pricing is not publicly disclosed; CDMO contracts are quote-based and dependent on formulation complexity, regulatory requirements, and volume. A January 2023 strategic growth investment by TA Associates (undisclosed amount) supports the ongoing Rs 50 crore capex program aimed at EU GMP compliance and capacity modernization, executed against a zero-debt balance sheet (per Nitin Lifesciences) and a stated historical sales milestone of Rs 8 billion.
Synokem Pharmaceuticals firmographics
Firmographics- Name
- Synokem Pharmaceuticals
- Legal name
- Synokem Pharmaceuticals Ltd.
- Website
- https://synokempharma.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Synokem Pharmaceuticals is an Indian CDMO and pharma manufacturer founded in 1983, operating three WHO-GMP-certified facilities that produce tablets, capsules, injectables, and hormonal products across 400+ formulations, serving pharmaceutical companies, government healthcare institutions, and export markets across 35+ countries.
- Ownership category
- akta.pro rank
Synokem Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Scientific Research and Development Services (5417), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industries
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Small-Molecule Generics (Branded/Unbranded) (HLAIABAA), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where Synokem Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Delhi
- HQ country
- India
- HQ region
- Asia
Offices5 records
Markets served
Synokem Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract Manufacturing / CDMO Services: High-quality development and manufacturing services to leading pharmaceutical companies, branded pharma firms, and biotechnology companies. Operates with Product-to-Product (P2P) and Loan License business models. Provides end-to-end support from formulation development to commercial manufacturing and packaging.
- Branded Generics (Ethical Division): Ethical promotion of prescription medicines to medical community throughout India. Premium prescription medications in various therapeutic areas with patient-centered care, affordability, and innovation.
- Institutional Sales: Supply of quality drugs to large government and semi-governmental departments, public sector hospitals, and state procurement organizations. Registered supplier of Indian Railways. Contributes to Jan Aushadhi program through PMBI supplies.
- International Business: Export operations serving markets across 6 continents with regulatory approvals from countries including Kenya, Sudan, Philippines, Uganda, Yemen, Nigeria, Nepal, and Sri Lanka.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Contract manufacturing services priced based on project requirements |
Go-to-market motion4 records
Distribution channels4 records
Marketing channels7 records
Synokem Pharmaceuticals product offering
Product offeringCore offering
Synokem Pharmaceuticals is a pharmaceutical CDMO and branded-generics manufacturer offering contract development and manufacturing services alongside its own branded prescription products. It produces tablets, capsules, oral liquids, ointments, hormonal products, and injectables across WHO-GMP certified facilities, serving global pharmaceutical clients and institutional buyers across 35+ countries through four verticals: Contract Manufacturing/CDMO, International Business, Institutional Business, and Branded Rx.
Product overview
Synokem Pharmaceuticals is a CDMO (Contract Development and Manufacturing Organization) and globally recognized pharmaceutical company founded in 1983. The company operates as an integrated pharmaceutical player with four interconnected business verticals: Contract Manufacturing/CDMO Services (offering end-to-end formulation development, analytical testing, manufacturing, and packaging), International Business (exporting WHO-GMP certified formulations to 35+ countries), Institutional Business (supplying government and public sector healthcare organizations including Jan Aushadhi program), and Branded Rx/Ethical Division (ethical promotion of prescription medicines in India). The company manufactures over 400 formulations across multiple dosage forms including tablets, capsules, oral liquids, ointments, hormonal products, and injectables through its three WHO-GMP certified facilities in Haridwar and via subsidiaries Synokem Lifesciences (tablets, capsules, liquids), Nitin Lifesciences (injectables, SVP), and Kemsyn Lifesciences (branded generics with 300+ SKUs).
Differentiator
Problem solved
Functional benefit
Products and services
- Contract Manufacturing and Development (CDMO) Services
- Branded Prescription Pharmaceuticals
- Institutional Pharmaceutical Supply
- International Pharmaceutical Exports
Quantifiable outcome
- Rs 8 Billion in sales achieved
- +3 more outcomes
Companies that use Synokem Pharmaceuticals
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles3 records
Synokem Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Synokem Pharmaceuticals partnerships and signals
Strategic signalScale indicators17 records
Recent moves8 records
Expansion highlights7 records
Synokem Pharmaceuticals competitors and assessment
Company assessmentBroad incumbents
- Aurobindo Pharma: Large Indian pharmaceutical manufacturer with significant CDMO operations and injectable manufacturing capabilities. A scaled peer competing in similar generics, injectables, and emerging-market export verticals.
- Divi's Laboratories: Leading Indian CDMO specializing in APIs and intermediates with US FDA and EU GMP certifications. Comparable in providing contract manufacturing services to global pharma, though at significantly larger scale.
- Jubilant Pharmova: Integrated Indian pharmaceutical company with CDMO services, generics, and radiopharmaceuticals. Comparable across CDMO, generics, and injectables manufacturing verticals.
Direct peers
- Syngene International: Biocon Group's integrated CDMO offering drug development and manufacturing services to global pharma. A closely comparable Indian CDMO peer, though with deeper biologics and discovery capabilities.
- Piramal Pharma Solutions: Global CDMO offering integrated development and manufacturing services across sterile injectables, oral solids, and APIs. Directly comparable in CDMO services and injectable manufacturing scope.
- Suven Pharmaceuticals: Indian CDMO focused on niche APIs, intermediates, and contract manufacturing. Comparable mid-sized Indian CDMO peer serving global innovator clients.
- Gland Pharma: India-based injectable-focused CDMO with strong US FDA presence, now majority-owned by Fosun. Direct peer in sterile injectables CDMO with comparable manufacturing capabilities and contract development services.
- Natco Pharma: Indian pharmaceutical company with formulation manufacturing, exports to emerging markets, and government/institutional supply. Comparable across branded generics, international business, and institutional verticals.
- Morepen Laboratories: Indian pharmaceutical manufacturer with APIs, formulations, and contract manufacturing. Comparable mid-sized Indian pharma peer across formulation CDMO and branded generics.
Regional players
- Bharat Parenterals: Indian injectables manufacturer specializing in small-volume parenterals. Direct comparable in sterile injectable CDMO capabilities with overlapping capacity profiles.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Synokem Pharmaceuticals social profiles
Digital presenceSynokem Pharmaceuticals compliance and trust
Trust signalCompliance5 records
Synokem Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synokem Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles2 records
Synokem Pharmaceuticals subsidiaries and ownership
Company hierarchySubsidiaries3 records
Synokem Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synokem Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synokem Pharmaceuticals
What does Synokem Pharmaceuticals do?
Synokem Pharmaceuticals is a pharmaceutical CDMO and branded-generics manufacturer offering contract development and manufacturing services alongside its own branded prescription products. It produces tablets, capsules, oral liquids, ointments, hormonal products, and injectables across WHO-GMP certified facilities, serving global pharmaceutical clients and institutional buyers across 35+ countries through four verticals: Contract Manufacturing/CDMO, International Business, Institutional Business, and Branded Rx.
Is Synokem Pharmaceuticals a public or private company?
Synokem Pharmaceuticals is a private company. It is classified as venture growth investor backed and is currently operating.
When was Synokem Pharmaceuticals founded?
Synokem Pharmaceuticals was founded in 1983. It employs 501 to 1,000 people.
Where is Synokem Pharmaceuticals based?
Synokem Pharmaceuticals is headquartered in Delhi, India, in the Asia region.
How does Synokem Pharmaceuticals make money?
Four revenue lines are on record. Contract Manufacturing / CDMO Services are the primary driver. The others are branded Generics (Ethical Division), institutional Sales and international Business.
Who are Synokem Pharmaceuticals's main competitors?
Broad incumbents on record are Aurobindo Pharma, Divi's Laboratories and Jubilant Pharmova. Direct peers are Syngene International, Piramal Pharma Solutions, Suven Pharmaceuticals, Gland Pharma, Natco Pharma and Morepen Laboratories. Bharat Parenterals is listed as a regional player.
Does Synokem Pharmaceuticals have an API?
No public API is recorded for Synokem Pharmaceuticals.
What industry is Synokem Pharmaceuticals in?
Synokem Pharmaceuticals's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO). Its NAICS code is 325412 and its SIC code is 2834.